Doxorubicin -eluting beads in the treatment of liver carcinoma.

Abstract

INTRODUCTION Doxorubicin and especially doxorubicin-eluting beads (DEBs) have become an intensive study subject in the locoregional therapy of liver carcinoma over the past 6 years. Since sorafenib has become the new standard in the treatment of advanced liver carcinoma and has been combined with DEB in clinical studies to evaluate safety and efficacy, it… (More)
DOI: 10.1517/14656566.2014.855719

Topics

1 Figure or Table

Cite this paper

@article{Vogl2014DoxorubicinB, title={Doxorubicin -eluting beads in the treatment of liver carcinoma.}, author={Thomas J. Vogl and Clara Lee}, journal={Expert opinion on pharmacotherapy}, year={2014}, volume={15 1}, pages={115-20} }